Cargando…

The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Francisella tularensis Strain SchuS4

The efficacy of the novel fluoroquinolone finafloxacin was evaluated as a potential therapeutic in vitro and in vivo, following an intranasal infection of Francisella tularensis strain SchuS4 in BALB/c mice. We demonstrated that short treatment courses of finafloxacin provide high levels of protecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barnes, Kay B., Hamblin, Karleigh A., Richards, Mark I., Laws, Thomas R., Vente, Andreas, Atkins, Helen S., Harding, Sarah V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504792/ https://www.ncbi.nlm.nih.gov/pubmed/31118924 http://dx.doi.org/10.3389/fmicb.2019.00904

Ejemplares similares

Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei
por: Barnes, Kay B., et al.
Publicado: (2017)

Global transcriptomic analysis of Francisella tularensis SchuS4 differentially expressed genes in response to doxycycline or ciprofloxacin exposure
por: Zaide, Galia, et al.
Publicado: (2023)

Low Dose Vaccination with Attenuated Francisella tularensis Strain SchuS4 Mutants Protects against Tularemia Independent of the Route of Vaccination
por: Rockx-Brouwer, Dedeke, et al.
Publicado: (2012)

Working correlates of protection predict SchuS4-derived-vaccine candidates with improved efficacy against an intracellular bacterium, Francisella tularensis
por: De Pascalis, Roberto, et al.
Publicado: (2022)

Efficacy of finafloxacin in a murine model of inhalational glanders
por: Barnes, Kay B., et al.
Publicado: (2022)

Differential Growth of Francisella tularensis, Which Alters Expression of Virulence Factors, Dominant Antigens, and Surface-Carbohydrate Synthases, Governs the Apparent Virulence of Ft SchuS4 to Immunized Animals
por: Holland, Kristen M., et al.
Publicado: (2017)

Identification of an Attenuated Substrain of Francisella tularensis SCHU S4 by Phenotypic and Genotypic Analyses
por: Lovchik, Julie A., et al.
Publicado: (2021)

Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever
por: Hartley, M. Gill, et al.
Publicado: (2021)

In Vitro Activity of Finafloxacin against Panels of Respiratory Pathogens
por: Harding, Sarah V., et al.
Publicado: (2023)

Role of Pathogenicity Determinant Protein C (PdpC) in Determining the Virulence of the Francisella tularensis Subspecies tularensis SCHU
por: Uda, Akihiko, et al.
Publicado: (2014)

Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates
por: Santiago, Araceli E., et al.
Publicado: (2015)

A Francisella tularensis Schu S4 Purine Auxotroph Is Highly Attenuated in Mice but Offers Limited Protection against Homologous Intranasal Challenge
por: Pechous, Roger D., et al.
Publicado: (2008)

In silico functional and structural characterization revealed virulent proteins of Francisella tularensis strain SCHU4
por: Goel, Prerna, et al.
Publicado: (2022)

Genome Sequencing Shows that European Isolates of Francisella tularensis Subspecies tularensis Are Almost Identical to US Laboratory Strain Schu S4
por: Chaudhuri, Roy R., et al.
Publicado: (2007)

Identification of Genes Contributing to the Virulence of Francisella tularensis SCHU S4 in a Mouse Intradermal Infection Model
por: Kadzhaev, Konstantin, et al.
Publicado: (2009)

CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols
por: Rozak, David A, et al.
Publicado: (2010)

Finafloxacin Is an Effective Treatment for Inhalational Tularemia and Plague in Mouse Models of Infection
por: Barnes, Kay B., et al.
Publicado: (2021)

Vaccine-Mediated Mechanisms Controlling Francisella tularensis SCHU S4 Growth in a Rat Co-Culture System
por: Lindgren, Helena, et al.
Publicado: (2020)

Global Analysis of Genes Essential for Francisella tularensis Schu S4 Growth In Vitro and for Fitness during Competitive Infection of Fischer 344 Rats
por: Ireland, Philip M., et al.
Publicado: (2019)

Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline
por: Kocsis, Béla, et al.
Publicado: (2021)

Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2
por: Qin, Aiping, et al.
Publicado: (2006)

Large Direct Repeats Flank Genomic Rearrangements between a New Clinical Isolate of Francisella tularensis subsp. tularensis A1 and Schu S4
por: Nalbantoglu, Ufuk, et al.
Publicado: (2010)

Characterization of Francisella tularensis Schu S4 mutants identified from a transposon library screened for O-antigen and capsule deficiencies
por: Rasmussen, Jed A., et al.
Publicado: (2015)

Components of the type six secretion system are substrates of Francisella tularensis Schu S4 DsbA-like FipB protein
por: Qin, Aiping, et al.
Publicado: (2016)

Two parallel pathways for ferric and ferrous iron acquisition support growth and virulence of the intracellular pathogen Francisella tularensis Schu S4
por: Pérez, Natalie, et al.
Publicado: (2016)

Whole genome transcriptomics reveals global effects including up-regulation of Francisella pathogenicity island gene expression during active stringent response in the highly virulent Francisella tularensis subsp. tularensis SCHU S4
por: Murch, Amber L., et al.
Publicado: (2017)

Characterization of Inner and Outer Membrane Proteins from Francisella tularensis Strains LVS and Schu S4 and Identification of Potential Subunit Vaccine Candidates
por: Post, Deborah M. B., et al.
Publicado: (2017)

Modeling early events in Francisella tularensis pathogenesis
por: Gillard, Joseph J., et al.
Publicado: (2014)

Protective effects of the Francisella tularensis ΔpdpC mutant against its virulent parental strain SCHU P9 in Cynomolgus macaques
por: Tian, Deyu, et al.
Publicado: (2019)

Stochastic dynamics of Francisella tularensis infection and replication
por: Carruthers, Jonathan, et al.
Publicado: (2020)

In Vitro Activity of Novel Topoisomerase Inhibitors against Francisella tularensis and Burkholderia pseudomallei
por: Whelan, Adam O., et al.
Publicado: (2023)

Francisella tularensis, Portugal
por: Lopes de Carvalho, Isabel, et al.
Publicado: (2007)

Etymologia: Francisella tularensis
por: Männikkö, Nancy
Publicado: (2011)

Roles for wbtC, wbtI, and kdtA Genes in Lipopolysaccharide Biosynthesis, Protein Glycosylation, Virulence, and Immunogenicity in Francisella tularensis Strain SCHU S4
por: Twine, Susan. M., et al.
Publicado: (2012)

Cytokine response in Balb/c mice infected with Francisella tularensis LVS and the Pohang isolate
por: Kim, Eun-Ju, et al.
Publicado: (2008)

Metapopulation structure for perpetuation of Francisella tularensis tularensis
por: Goethert, Heidi K, et al.
Publicado: (2009)

Demonstration of the Broad-Spectrum In Vitro Activity of Finafloxacin against Pathogens of Biodefense Interest
por: Barnes, Kay B., et al.
Publicado: (2019)

Comparative review of Francisella tularensis and Francisella novicida
por: Kingry, Luke C., et al.
Publicado: (2014)

An In Vitro Co-culture Mouse Model Demonstrates Efficient Vaccine-Mediated Control of Francisella tularensis SCHU S4 and Identifies Nitric Oxide as a Predictor of Efficacy
por: Golovliov, Igor, et al.
Publicado: (2016)

Regulation of Francisella Tularensis Virulence
por: Dai, Shipan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3onff7hkrghgbo7j4pbp56na6s